Naoki Fujita

25PUBLICATIONS
39CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Neurology and neuromuscular diseasesMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|May 26, 2026
Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study.

|May 12, 2026
Editorial Comments to "Prognostic Significance of Hypoalbuminemia in Maintenance Avelumab Therapy After First-Line Chemotherapy for Metastatic Urothelial Carcinoma: A Multicenter Real-World Study (YUSHIMA Study)".

|Apr 02, 2026
Editorial Comments to "Palliative Intra-Arterial Chemotherapy Without Radiotherapy for Elderly Patients With Muscle-Invasive Bladder Cancer: A Single-Center Retrospective Comparison With Radical Cystectomy and Best Supportive Care".

Naoki Fujita

|Mar 23, 2026
Association of Prophylactic Intravenous Corticosteroid Premedication With Toxicity and Survival in Patients Receiving Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Carcinoma.

Masanao Shinohara, Hayato Yamamoto, Yohei Kawashima

|Mar 08, 2026
Overactive Bladder Symptoms as a Predictor of Longitudinal Decline in Grip Strength in Community-Dwelling Men: A 4-Year Longitudinal Study.

Hiroyuki Sato, Teppei Okamoto, Tomoko Hamaya

|Jan 21, 2026
Deferred Cytoreductive Nephrectomy in Unresectable/Metastatic Renal Cell Carcinoma: A Real-World Multicenter Retrospective Study.

Ryuma Tanaka, Masanao Shinohara, Yohei Kawashima

Pageof 5

Frequent Collaborators

17 joint publications

Shingo Hatakeyama

6 joint publications

Hirotake Kodama

5 joint publications

Tohru Yoneyama

5 joint publications

Teppei Okamoto